Search Results - "Bartoni, Kathy"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Randomized Comparison of Sulbactam/Cefoperazone with Imipenem as Empirical Monotherapy for Febrile Granulocytopenic Patients by Winston, Drew J., Bartoni, Kathy, Bruckner, David A., Schiller, Gary J., Territo, Mary C.

    Published in Clinical infectious diseases (01-03-1998)
    “…In a prospective, randomized, controlled trial, we compared sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile, granulocytopenic…”
    Get full text
    Journal Article
  2. 2

    Randomized Comparison of Oral Valacyclovir and Intravenous Ganciclovir for Prevention of Cytomegalovirus Disease after Allogeneic Bone Marrow Transplantation by Winston, Drew J., Yeager, Andrew M., Chandrasekar, Pranatharthi H., Snydman, David R., Petersen, Finn Bo, Territo, Mary C.

    Published in Clinical infectious diseases (15-03-2003)
    “…In this multicenter, randomized study, cytomegalovirus (CMV)-seropositive patients who received an allogeneic bone marrow transplant were provided high-dose…”
    Get full text
    Journal Article
  3. 3

    Efficacy, Safety, and Breakthrough Infections Associated with Standard Long-Term Posaconazole Antifungal Prophylaxis in Allogeneic Stem Cell Transplantation Recipients by Winston, Drew J, Bartoni, Kathy, Territo, Mary C, Schiller, Gary J

    “…Based on favorable results from randomized clinical trials, oral posaconazole has been approved for prophylaxis in neutropenic patients and stem cell…”
    Get full text
    Journal Article
  4. 4

    Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients : results of a placebo-controlled, double-blind trial by WINSTON, D. J, HO, W. G, BARTONI, K, DU MOND, C, EBELING, D. F, BUHLES, W. C, CHAMPLIN, R. E

    Published in Annals of internal medicine (01-02-1993)
    “…To evaluate the efficacy and safety of ganciclovir for prevention of cytomegalovirus (CMV) infection and disease. A randomized, placebo-controlled,…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Ganciclovir Therapy for Cytomegalovirus Infections in Recipients of Bone Marrow Transplants and Other Immunosuppressed Patients by Drew J. Winston, Winston G. Ho, Kathy Bartoni, Gary N. Holland, Mitsuyasu, Ronald T., Robert P. Gale, Busuttil, Ronald W., Richard E. Champlin

    Published in Reviews of infectious diseases (01-07-1988)
    “…The efficacy and safety of ganciclovir were evaluated for the treatment of 39 life-threatening or sight-threatening cytomegalovirus (CMV) infections in…”
    Get full text
    Journal Article